Sectors
ATYR
aTyr Pharma, Inc.
0.56
5 x 0.52
2 x 0.58
bid
ask
+
0.01
1.08%
1 @ 04:00 PM
0.53 -0.03 (6.08%)
| Ytd | -28.61% | |
| 1y | -88.80% |
0.56
day range
0.59
0.40
52 week range
6.03
| Open | 0.56 | Prev Close | 0.55 | Low | 0.56 | High | 0.59 | Mkt Cap | 54.81M |
| Vol | 648.06K | Avg Vol | 2.06M | EPS | 0.02 | P/E | 27.95 | Forward P/E | -4.33 |
| Beta | 1.10 | Short Ratio | 2.66 | Inst. Own | 63.15% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 0.51 | 200-d Avg | 0.72 | 1yr Est | 21.29 |
| Income Statement | |||
| Operating Expenses | 10.88M | ||
| Research and Development Expense | 6.75M | ||
| Selling, General and Administrative Expense | 4.13M | ||
| Operating Income | -10.88M | ||
| Net Income | -10.31M | ||
| Net Income Common Stock | -10.31M | ||
| Net Income Common Stock (USD) | -10.31M | ||
| Consolidated Income | -10.31M | ||
| Net Income to Non-Controlling Interests | -1000 | ||
| Earnings per Basic Share | -0.11 | ||
| Earnings per Basic Share (USD) | -0.11 | ||
| Earnings per Diluted Share | -0.11 | ||
| Earning Before Interest & Taxes (EBIT) | -10.31M | ||
| Earning Before Interest & Taxes (USD) | -10.31M | ||
| Weighted Average Shares | 98.07M | ||
| Weighted Average Shares Diluted | 98.07M | ||
| Balance Sheet | |||
| Cash and Equivalents | 17.66M | ||
| Cash and Equivalents (USD) | 17.66M | ||
| Investments | 41.26M | ||
| Investments Current | 41.26M | ||
| Trade and Non-Trade Receivables | 426.00K | ||
| Current Assets | 58.36M | ||
| Property, Plant & Equipment Net | 9.78M | ||
| Total Assets | 69.83M | ||
| Debt Current | 1.46M | ||
| Total Debt | 11.30M | ||
| Current Liabilities | 11.40M | ||
| Debt Non-Current | 9.84M | ||
| Total Liabilities | 21.23M | ||
| Accumulated Retained Earnings (Deficit) | -627.26M | ||
| Accumulated Other Comprehensive Income | -68.00K | ||
| Shareholders Equity | 48.79M | ||
| Shareholders Equity (USD) | 48.79M | ||
| Assets Non-Current | 11.46M | ||
| Total Debt (USD) | 11.30M | ||
| Liabilities Non-Current | 9.84M | ||
| Trade and Non-Trade Payables | 3.24M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 405.00K | ||
| Net Cash Flow from Financing | -129.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 5.84M | ||
| Capital Expenditure | -73.00K | ||
| Issuance (Purchase) of Equity Shares | 16.00K | ||
| Issuance (Repayment) of Debt Securities | -145.00K | ||
| Net Cash Flow from Investing | 15.32M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 15.40M | ||
| Net Cash Flow from Operations | -9.35M | ||
| Share Based Compensation | 1.15M | ||